Comparison of Kinesio Taping and Myofascial Release in Cervicogenic Headache
Comparison of the Effectiveness of Kinesio Taping and Myofascial Release in Patients With Cervicogenic Headache
1 other identifier
interventional
81
1 country
1
Brief Summary
Cervicogenic headache (CGH) is defined as a headache accompanied by neck pain, caused by a disorder in the cervical spine, bones, discs, or soft tissue elements. This study is designed as a prospective, case-control, hospital-based study. A total of 90 patients aged 18-65 years who have been suffering from CGH for at least three months and who present to the Physical Medicine and Rehabilitation Clinic of Meram State Hospital between January 2025 and January 2027 will be included in the study. Patients will be informed about the procedures, and informed consent will be obtained. The study will be conducted in accordance with the Declaration of Helsinki. A detailed medical history will be taken from all participants, and a comprehensive physical examination will be performed. Sociodemographic and clinical characteristics such as age, gender, height, weight, education level, employment status, and income level will be recorded. The 90 CGH patients will be divided into three groups.Group 1 (n=30) will receive myofascial release therapy + home exercise program for four weeks, three sessions per week, totaling 12 sessions. Group 2 (n=30) will receive Kinesio taping + home exercise program for four weeks, three sessions per week, totaling 12 sessions. Group 3 (n=30) will receive only a home exercise program for four weeks, three sessions per week, totaling 12 sessions. All evaluations will be conducted by the same researcher at three time points: before treatment (baseline), at the end of treatment (week 4), and one month after the completion of treatment (week 8).The aim of this prospective clinical study is to compare the effectiveness of Kinesio taping and myofascial release therapy in the treatment of cervicogenic headache.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
April 9, 2025
CompletedFirst Posted
Study publicly available on registry
April 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedNovember 19, 2025
November 1, 2025
6 months
April 9, 2025
November 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Cervicogenic Headache Severity Measured by Visual Analog Scale (VAS) at Baseline, 4 Weeks, and 8 Weeks
Headache severity will be assessed using a 10 cm horizontal Visual Analog Scale (VAS), where 0 indicates "no pain" and 10 indicates "worst possible pain." Participants will mark the level of their current headache severity on the scale. Changes will be calculated from baseline to week 4 and week 8.
Baseline, Week 4 (end of treatment), and Week 8 (1-month follow-up after treatment)
Secondary Outcomes (4)
Change in Headache Impact Test (HIT-6) Score at Baseline, 4 Weeks, and 8 Weeks
Baseline, Week 4, and Week 8
Change in Headache Disability Index (HDI) Score at Baseline, 4 Weeks, and 8 Weeks
Baseline, Week 4, and Week 8
Change in Quality of Life Measured by Short Form-12 (SF-12) at Baseline, 4 Weeks, and 8 Weeks
Baseline, Week 4, and Week 8
Change in Headache Frequency (Number of Headache Days per Month) at Baseline, 4 Weeks, and 8 Weeks
Baseline, Week 4, and Week 8
Study Arms (3)
Myofascial Release Group
EXPERIMENTALGroup 1 (n=30) will receive myofascial release therapy + home exercise program for four weeks, three sessions per week, totaling 12 sessions.
Kinesiology Taping Group
EXPERIMENTALGroup 2 (n=30) will receive Kinesio taping + home exercise program for four weeks, three sessions per week, totaling 12 sessions
Home Exercise Group
EXPERIMENTALGroup 3 (n=30) will receive only a home exercise program for four weeks, three sessions per week, totaling 12 sessions
Interventions
myofascial release therapy combined with a home exercise program: Myofascial release techniques will be applied manually to the cervical and upper trapezius regions by a trained physiotherapist. The intervention will be administered three times per week for four weeks, totaling 12 sessions. In addition, participants will follow a standardized home exercise program designed to improve cervical mobility and reduce muscle tension.
kinesiology taping combined with a home exercise program : Kinesiology tape will be applied to the cervical region following a standardized taping protocol. The taping will be performed by a trained physiotherapist three times per week for four weeks, totaling 12 sessions. The tape will remain on the skin for 3-5 days per application.
Home exercise program: The exercise program includes cervical mobility exercises, stretching, and strengthening exercises aimed at improving posture and reducing muscle tension. The intervention will be performed three times per week for four weeks, totaling 12 sessions.
Eligibility Criteria
You may qualify if:
- Meeting the diagnostic criteria for cervicogenic headache, including:
- Unilateral pain
- Reduced cervical range of motion
- Ipsilateral shoulder discomfort
- Ipsilateral arm discomfort
- Pain exacerbated by different neck movements and tenderness on palpation
You may not qualify if:
- Migraine Cluster headache Cervical radiculopathy Entrapment neuropathy Myelopathy Rheumatoid arthritis Undergoing cervical spinal surgery Pregnancy Receiving physical therapy within the last 6 months History of major psychiatric disorders History of uncontrolled systemic diseases (cardiovascular, pulmonary, hepatic, renal, hematological, etc.) History of uncontrolled endocrine diseases (e.g., Diabetes Mellitus, hyperthyroidism, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Meram State Hospital
Konya, Meram, 42090, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Only the outcomes assessor was blinded to group allocation to reduce measurement bias. Participants and care providers were aware of the intervention being applied.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor, Physical Medicine and Rehabilitation
Study Record Dates
First Submitted
April 9, 2025
First Posted
April 23, 2025
Study Start
February 1, 2025
Primary Completion
August 1, 2025
Study Completion
August 31, 2025
Last Updated
November 19, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- January 2026 - January 2029
- Access Criteria
- Qualified researchers with methodologically sound proposals will be able to request access to de-identified individual participant data (IPD), the study protocol, and the statistical analysis plan. Access will be provided upon reasonable request by contacting the Principal Investigator via institutional email. A data sharing agreement may be required before access is granted.
De-identified individual participant data (IPD) for all primary and secondary outcome measures (e.g., VAS, HIT-6, NDI, SF-12) will be made available to qualified researchers for secondary analysis. Data will be shared upon reasonable request, beginning 6 months after publication, for a period of 3 years. Access will be granted to researchers with methodologically sound proposals by contacting the Principal Investigator via institutional email.